Vascular amine oxidase activities during synergistic vasculotoxicity

Margaret B. Trent, Paul J. Boor

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Allylamine (AA) and β-aminopropionitrile (βAPN) are well known vascular toxins with a demonstrated synergistic toxic effect, i.e. given together they cause extensive smooth muscle cell necrosis of the aortic media. In this study, we investigated the possibility that the enzymes involved in the separate toxicity of AA (semicarbazide-sensitive amine oxidase, or SSAO) and βAPN (lysyl oxidase, or LyO), could be the target(s) of their synergistic toxicity. Adult male Sprague-Dawley rats were given AA alone (AA), 100 mg/kg/day, βAPN alone (βAPN), 1 g/kg/day, or both chemicals (AA + βAPN) by gavage for 1, 2, 5 or 10 days. SSAO and LyO were assayed in aorta, lung, and bone. SSAO activity in aortas of rats treated with AA + βAPN showed a maximal decrease (40%) at 10 days; more moderate depression of SSAO was seen in lung and bone. LyO changes were most marked in aorta, where activities were consistently and markedly depressed in all rats receiving βAPN (either alone or in combined treatment). Similarly, the lung and bone LyO activity was depressed at all time points in rats receiving βAPN, but to an apparently lesser degree than in aorta. The most striking changes in in vivo enzyme activities were seen in the aorta, the major target organ in this model. No synergistic effect of the two toxins was seen in the depression of LyO enzyme activity, since there was no difference in the degree of enzyme inhibition present between rats given βAPN alone or AA + βAPN, indicating that inhibition of this enzyme is mainly due to the effect of βAPN. We suggest that AA is the primary toxin in this synergistic vasculotoxic effect. It is likely that some effect of βAPN on AA metabolism or detoxification mechanisms results in synergism.

Original languageEnglish (US)
Pages (from-to)67-77
Number of pages11
JournalToxicology
Volume89
Issue number1
DOIs
StatePublished - Mar 25 1994

Fingerprint

Aminopropionitrile
Allylamine
Amines
Blood Vessels
Oxidoreductases
Aorta
Rats
Enzymes
Bone
Enzyme activity
Bone and Bones
Lung
Toxicity
Protein-Lysine 6-Oxidase
Amine Oxidase (Copper-Containing)
Enzyme inhibition
Detoxification
Poisons
Metabolism

Keywords

  • Allylamine
  • Aorta
  • Lysyl oxidase
  • Semicarbazide-sensitive amine oxidase
  • Vascular toxicity
  • β-aminopropionitrile

ASJC Scopus subject areas

  • Toxicology

Cite this

Vascular amine oxidase activities during synergistic vasculotoxicity. / Trent, Margaret B.; Boor, Paul J.

In: Toxicology, Vol. 89, No. 1, 25.03.1994, p. 67-77.

Research output: Contribution to journalArticle

Trent, Margaret B. ; Boor, Paul J. / Vascular amine oxidase activities during synergistic vasculotoxicity. In: Toxicology. 1994 ; Vol. 89, No. 1. pp. 67-77.
@article{5cb0868ab72443f2b00498ed4fbbb827,
title = "Vascular amine oxidase activities during synergistic vasculotoxicity",
abstract = "Allylamine (AA) and β-aminopropionitrile (βAPN) are well known vascular toxins with a demonstrated synergistic toxic effect, i.e. given together they cause extensive smooth muscle cell necrosis of the aortic media. In this study, we investigated the possibility that the enzymes involved in the separate toxicity of AA (semicarbazide-sensitive amine oxidase, or SSAO) and βAPN (lysyl oxidase, or LyO), could be the target(s) of their synergistic toxicity. Adult male Sprague-Dawley rats were given AA alone (AA), 100 mg/kg/day, βAPN alone (βAPN), 1 g/kg/day, or both chemicals (AA + βAPN) by gavage for 1, 2, 5 or 10 days. SSAO and LyO were assayed in aorta, lung, and bone. SSAO activity in aortas of rats treated with AA + βAPN showed a maximal decrease (40{\%}) at 10 days; more moderate depression of SSAO was seen in lung and bone. LyO changes were most marked in aorta, where activities were consistently and markedly depressed in all rats receiving βAPN (either alone or in combined treatment). Similarly, the lung and bone LyO activity was depressed at all time points in rats receiving βAPN, but to an apparently lesser degree than in aorta. The most striking changes in in vivo enzyme activities were seen in the aorta, the major target organ in this model. No synergistic effect of the two toxins was seen in the depression of LyO enzyme activity, since there was no difference in the degree of enzyme inhibition present between rats given βAPN alone or AA + βAPN, indicating that inhibition of this enzyme is mainly due to the effect of βAPN. We suggest that AA is the primary toxin in this synergistic vasculotoxic effect. It is likely that some effect of βAPN on AA metabolism or detoxification mechanisms results in synergism.",
keywords = "Allylamine, Aorta, Lysyl oxidase, Semicarbazide-sensitive amine oxidase, Vascular toxicity, β-aminopropionitrile",
author = "Trent, {Margaret B.} and Boor, {Paul J.}",
year = "1994",
month = "3",
day = "25",
doi = "10.1016/0300-483X(94)90133-3",
language = "English (US)",
volume = "89",
pages = "67--77",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Vascular amine oxidase activities during synergistic vasculotoxicity

AU - Trent, Margaret B.

AU - Boor, Paul J.

PY - 1994/3/25

Y1 - 1994/3/25

N2 - Allylamine (AA) and β-aminopropionitrile (βAPN) are well known vascular toxins with a demonstrated synergistic toxic effect, i.e. given together they cause extensive smooth muscle cell necrosis of the aortic media. In this study, we investigated the possibility that the enzymes involved in the separate toxicity of AA (semicarbazide-sensitive amine oxidase, or SSAO) and βAPN (lysyl oxidase, or LyO), could be the target(s) of their synergistic toxicity. Adult male Sprague-Dawley rats were given AA alone (AA), 100 mg/kg/day, βAPN alone (βAPN), 1 g/kg/day, or both chemicals (AA + βAPN) by gavage for 1, 2, 5 or 10 days. SSAO and LyO were assayed in aorta, lung, and bone. SSAO activity in aortas of rats treated with AA + βAPN showed a maximal decrease (40%) at 10 days; more moderate depression of SSAO was seen in lung and bone. LyO changes were most marked in aorta, where activities were consistently and markedly depressed in all rats receiving βAPN (either alone or in combined treatment). Similarly, the lung and bone LyO activity was depressed at all time points in rats receiving βAPN, but to an apparently lesser degree than in aorta. The most striking changes in in vivo enzyme activities were seen in the aorta, the major target organ in this model. No synergistic effect of the two toxins was seen in the depression of LyO enzyme activity, since there was no difference in the degree of enzyme inhibition present between rats given βAPN alone or AA + βAPN, indicating that inhibition of this enzyme is mainly due to the effect of βAPN. We suggest that AA is the primary toxin in this synergistic vasculotoxic effect. It is likely that some effect of βAPN on AA metabolism or detoxification mechanisms results in synergism.

AB - Allylamine (AA) and β-aminopropionitrile (βAPN) are well known vascular toxins with a demonstrated synergistic toxic effect, i.e. given together they cause extensive smooth muscle cell necrosis of the aortic media. In this study, we investigated the possibility that the enzymes involved in the separate toxicity of AA (semicarbazide-sensitive amine oxidase, or SSAO) and βAPN (lysyl oxidase, or LyO), could be the target(s) of their synergistic toxicity. Adult male Sprague-Dawley rats were given AA alone (AA), 100 mg/kg/day, βAPN alone (βAPN), 1 g/kg/day, or both chemicals (AA + βAPN) by gavage for 1, 2, 5 or 10 days. SSAO and LyO were assayed in aorta, lung, and bone. SSAO activity in aortas of rats treated with AA + βAPN showed a maximal decrease (40%) at 10 days; more moderate depression of SSAO was seen in lung and bone. LyO changes were most marked in aorta, where activities were consistently and markedly depressed in all rats receiving βAPN (either alone or in combined treatment). Similarly, the lung and bone LyO activity was depressed at all time points in rats receiving βAPN, but to an apparently lesser degree than in aorta. The most striking changes in in vivo enzyme activities were seen in the aorta, the major target organ in this model. No synergistic effect of the two toxins was seen in the depression of LyO enzyme activity, since there was no difference in the degree of enzyme inhibition present between rats given βAPN alone or AA + βAPN, indicating that inhibition of this enzyme is mainly due to the effect of βAPN. We suggest that AA is the primary toxin in this synergistic vasculotoxic effect. It is likely that some effect of βAPN on AA metabolism or detoxification mechanisms results in synergism.

KW - Allylamine

KW - Aorta

KW - Lysyl oxidase

KW - Semicarbazide-sensitive amine oxidase

KW - Vascular toxicity

KW - β-aminopropionitrile

UR - http://www.scopus.com/inward/record.url?scp=0028256146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028256146&partnerID=8YFLogxK

U2 - 10.1016/0300-483X(94)90133-3

DO - 10.1016/0300-483X(94)90133-3

M3 - Article

C2 - 7909964

AN - SCOPUS:0028256146

VL - 89

SP - 67

EP - 77

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 1

ER -